相关实验视频
Updated: May 28, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
在性结肠炎和性脊柱炎中共享的基因和途径:功能验证和诊断的影响
Lin Li1, Guangqi An1, Fuzhen Li1
1Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Henan Province Eye Hospital, Henan International Joint Research Laboratory for Ocular Immunology and Retinal Injury Repair, Zhengzhou, Henan, People's Republic of China.
这项研究确定了性结肠炎 (UC) 和性脊柱炎 (AS) 的共享基因和途径. 这些发现可能会改善这些相关炎症状况的诊断和治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 和性脊柱炎 (AS) 分享报告的关联,但它们的共同病因尚未完全理解.
- 调查共享的遗传因素和机制对于理解UC和AS之间的关系至关重要.
研究的目的:
- 确定共享的基因和阐明性结肠炎 (UC) 和性脊柱炎 (AS) 的相关生物机制.
- 发现UC和AS的潜在诊断生物标志物和治疗点.
主要方法:
- 对UC和AS数据集 (GSE113079,GSE1797879) 进行了差异基因表达分析,以确定常见的差异表达基因 (DEG).
- 使用受体操作特征 (ROC) 曲线分析,基因组丰富分析 (GSEA) 和免疫透分析来识别关键基因和通路.
- 反转录聚合酶链反应 (RT-PCR) 用于验证患者样本中关键基因的mRNA表达.
主要成果:
- 八个关键基因 (GMFG,GNG11,CLEC4D,CMTM2,VAMP5,S100A8,S100A12,DGKQ) 被确定为AS和UC的潜在诊断生物标志物.
- 包括rimegepant,eptinezumab,methotrexate,atogepant和 ubrogepant在内的药物被建议作为潜在的针对S100A12和S100A8.8的治疗方法.
- GSEA揭示了与抗原处理,自然杀手细胞细胞毒性和T细胞受体信号通路的关联. 在患者中观察到S100A12,VAMP5和CLEC4D的mRNA表达增加.
结论:
- 该研究确定了关键基因和共享途径,增强了对UC和AS关系的理解.
- 这些发现可能有助于为患有UC和AS的患者制定更好的诊断和治疗策略.
更多相关视频
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Ulcerative Colitis in IBD
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...